Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. CLINICAL TRIAL COLLABORATION AGREEMENTTrial Collaboration Agreement • February 25th, 2013 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • New York
This CLINICAL TRIAL COLLABORATION AGREEMENT (the “Agreement”) is made and entered into as of the date of the last signature affixed hereto (the “Effective Date”) by and between Idenix Pharmaceuticals, Inc., a Delaware corporation with a place of business at 60 Hampshire Street, Cambridge, MA 02139 (“Idenix”); and Janssen Pharmaceuticals, Inc., a Pennsylvania corporation with a place of business at 1125 Trenton-Harbourton Road, Titusville, New Jersey 08560 (“Janssen”). Idenix and Janssen may be referred to herein individually as a “Party,” or collectively as the “Parties.”
